These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38744199)

  • 1. Identification of Scutebarbatine B metabolites in rats using UHPLC-Q-Orbitrap-MS/MS and exploration of its mechanism of reversal multidrug resistance in breast cancer by network pharmacology and molecular docking studies.
    Zhang H; Wang H; Gao X; Wang G; Sun L
    J Pharm Biomed Anal; 2024 Aug; 246():116207. PubMed ID: 38744199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. neo-Clerodane diterpenoids from Scutellaria barbata mediated inhibition of P-glycoprotein in MCF-7/ADR cells.
    Xue GM; Xia YZ; Wang ZM; Li LN; Luo JG; Kong LY
    Eur J Med Chem; 2016 Oct; 121():238-249. PubMed ID: 27240278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
    J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the Metabolites of Scutebarbatine A in Rat Plasma, Bile, Urine, and feces by Using Ultra-high-performance Liquid Chromatography Coupled with Q Exactive Hybrid Quadrupole-orbitrap High-resolution Mass Spectrometry.
    Zhao L; Wang H; Yuan N; Yang G; Gao J; Sun L
    Curr Drug Metab; 2022; 23(1):30-37. PubMed ID: 35081887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of bicyclol metabolites in rat plasma, urine and feces by UPLC-Q-TOF-MS/MS and evaluation of the efficacy and safety of these metabolites based on network pharmacology and molecular docking combined with toxicity prediction.
    Huang X; Jia M; Liu Y; Wang S; Tang Y; Li X; Jiang X; Wu Z; Lou Y; Fan G
    J Pharm Biomed Anal; 2022 Oct; 220():114947. PubMed ID: 35985135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry.
    Zhang R; Zhuang X; Zong L; Liu S; Liu Z; Song F
    Anal Bioanal Chem; 2016 Aug; 408(21):5843-5854. PubMed ID: 27379392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lathyrane diterpenes from Euphorbia lathyris and the potential mechanism to reverse the multi-drug resistance in HepG2/ADR cells.
    Yang T; Wang S; Li H; Zhao Q; Yan S; Dong M; Liu D; Chen X; Li R
    Biomed Pharmacother; 2020 Jan; 121():109663. PubMed ID: 31751870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic characterization of the absorbed components of Ligustri Lucidi Fructus and their metabolic pathways in rat plasma by ultra-high-performance liquid chromatography-Q-Exactive Orbitrap tandem mass spectrometry combined with network pharmacology.
    Zhang D; Xiong L; Fang L; Li H; Zhao X; Luan R; Zhao P; Zhang X
    J Sep Sci; 2021 Dec; 44(24):4343-4367. PubMed ID: 34687589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
    Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
    Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diterpenoids from Euphorbia glomerulans with potential reversal activities against P-glycoprotein-mediated multidrug resistance.
    Hasan A; Tang D; Nijat D; Yang H; Aisa HA
    Bioorg Chem; 2021 Dec; 117():105442. PubMed ID: 34742027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells.
    Sinha BK; Perera L; Cannon RE
    Biomed Pharmacother; 2019 Dec; 120():109468. PubMed ID: 31605952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics analysis of multidrug resistance in colorectal cancer cell and multidrug resistance reversal effect of verapamil.
    Wang X; Wang Z; Wang K; Gao M; Zhang H; Xu X
    Biomed Chromatogr; 2021 Feb; 35(2):e4976. PubMed ID: 32852057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.